The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
Open accessAbstract
Targeting DLL3 with an antibody-drug conjugate eliminates tumor-initiating cells in high-grade pulmonary neuroendocrine cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Rudin, C. M., Durinck, S., Stawiski, E. W., Poirier, J. T., Modrusan, Z., Shames, D. S., Bergbower, E. A., Guan, Y., Shin, J., Guillory, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2405 · Cited by 1,077
Self-citationGuillemot, F., Lo, L.-C., Johnson, J. E., Auerbach, A., Anderson, D. J., & Joyner, A. L. (1993) · Cell · doi:10.1016/0092-8674(93)90381-y · Cited by 1,033
Fehon, R. G., Kooh, P. J., Rebay, I., Regan, C. L., Xu, T., Muskavitch, M. A. T., & Artavanis-Tsakonas, S. (1990) · Cell · doi:10.1016/0092-8674(90)90534-l · Cited by 673
Dubowchik, G. M., Firestone, R. A., Padilla, L., Willner, D., Hofstead, S. J., Mosure, K., Knipe, J. O., Lasch, S. J., & Trail, P. A. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025536j · Cited by 555
Sutherland, K. D., Proost, N., Brouns, I., Adriaensen, D., Song, J.-Y., & Berns, A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.019 · Cited by 534
A Genomics-Based Classification of Human Lung Tumors
The Clinical Lung Cancer Genome Project (CLCGP) and Network Genomic Medicine (NGM) (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006802 · Cited by 511
An achaete-scute homologue essential for neuroendocrine differentiation in the lung
Borges, M., Linnoila, R. I., van de Velde, H. J. K., Chen, H., Nelkin, B. D., Mabry, M., Baylin, S. B., & Ball, D. W. (1997) · Nature · doi:10.1038/386852a0 · Cited by 454
Reynolds, S. D., Giangreco, A., Power, J. H. T., & Stripp, B. R. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64727-x · Cited by 447
Neuroendocrine Tumors of the Lung: An Update
Rekhtman, N. (2010) · Archives of Pathology and Laboratory Medicine · doi:10.5858/2009-0583-rar.1 · Cited by 445
Ito, T., Udaka, N., Yazawa, T., Okudela, K., Hayashi, H., Sudo, T., Guillemot, F., Kageyama, R., & Kitamura, H. (2000) · Development · doi:10.1242/dev.127.18.3913 · Cited by 404
From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling
Ntziachristos, P., Lim, J. S., Sage, J., & Aifantis, I. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.018 · Cited by 374
Dunwoodie, S. L., Henrique, D., Harrison, S. M., & Beddington, R. S. P. (1997) · Development · doi:10.1242/dev.124.16.3065 · Cited by 368
Lineage dependency and lineage-survival oncogenes in human cancer
Garraway, L. A., & Sellers, W. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1947 · Cited by 360
von Pawel, J., Jotte, R., Spigel, D. R., O'Brien, M. E. R., Socinski, M. A., Mezger, J., Steins, M., Bosquée, L., Bubis, J., Nackaerts, K., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.5392 · Cited by 352
Advances in neuroendocrine lung tumors
Travis, W. D. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq380 · Cited by 327
Self-citationSong, H., Yao, E., Lin, C., Gacayan, R., Chen, M.-H., & Chuang, P.-T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207238109 · Cited by 311
Ladi, E., Nichols, J. T., Ge, W., Miyamoto, A., Yao, C., Yang, L.-T., Boulter, J., Sun, Y. E., Kintner, C., & Weinmaster, G. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503113 · Cited by 282
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers
Augustyn, A., Borromeo, M., Wang, T., Fujimoto, J., Shao, C., Dospoy, P. D., Lee, V., Tan, C., Sullivan, J. P., Larsen, J. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410419111 · Cited by 282
Notch inhibitors for cancer treatment
Espinoza, I., & Miele, L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.02.003 · Cited by 273
Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure
Pagliarini, R., Shao, W., & Sellers, W. R. (2015) · EMBO reports · doi:10.15252/embr.201439949 · Cited by 253
Poirier, J. T., Gardner, E. E., Connis, N., Moreira, A. L., de Stanchina, E., Hann, C. L., & Rudin, C. M. (2015) · Oncogene · doi:10.1038/onc.2015.38 · Cited by 248
Self-citationProtease-Activated Drug Development
Choi, K. Y., Swierczewska, M., Lee, S., & Chen, X. (2012) · Theranostics · doi:10.7150/thno.4068 · Cited by 245
Characterization of the cell of origin for small cell lung cancer
Park, K.-S., Liang, M.-C., Raiser, D. M., Zamponi, R., Roach, R. R., Curtis, S. J., Walton, Z., Schaffer, B. E., Roake, C. M., Zmoos, A.-F., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.16.17012 · Cited by 227
Morimoto, M., Nishinakamura, R., Saga, Y., & Kopan, R. (2012) · Development · doi:10.1242/dev.083840 · Cited by 213
Chapman, G., Sparrow, D. B., Kremmer, E., & Dunwoodie, S. L. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq529 · Cited by 196
Antibody–drug conjugates—A new wave of cancer drugs
Bouchard, H., Viskov, C., & Garcia-Echeverria, C. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.10.021 · Cited by 190
Williams, S. A., Anderson, W. C., Santaguida, M. T., & Dylla, S. J. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.92 · Cited by 186
Self-citationJiang, T., Collins, B. J., Jin, N., Watkins, D. N., Brock, M. V., Matsui, W., Nelkin, B. D., & Ball, D. W. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2762 · Cited by 186
Tumor Suppressor Role of Notch-1 Signaling in Neuroendocrine Tumors
Kunnimalaiyaan, M., & Chen, H. (2007) · The Oncologist · doi:10.1634/theoncologist.12-5-535 · Cited by 186
Rosfjord, E., Lucas, J., Li, G., & Gerber, H.-P. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.06.008 · Cited by 177
Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo
Geffers, I., Serth, K., Chapman, G., Jaekel, R., Schuster-Gossler, K., Cordes, R., Sparrow, D. B., Kremmer, E., Dunwoodie, S. L., Klein, T., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200702009 · Cited by 163
Pathology and Diagnosis of Neuroendocrine Tumors
Travis, W. D. (2014) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2014.04.001 · Cited by 152
Self-citationAscl1 and Neurog2 form novel complexes and regulate Delta-like3 (Dll3) expression in the neural tube
Henke, R. M., Meredith, D. M., Borromeo, M. D., Savage, T. K., & Johnson, J. E. B. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.01.007 · Cited by 141
Hartley, J. A., Spanswick, V. J., Brooks, N. A., Clingen, P. H., McHugh, P. J., Hochhauser, D., Pedley, R. B., Kèlland, L. R., Alley, M. C., Schultz, R. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2941 · Cited by 138
Self-citationSelective Tropism of Seneca Valley Virus for Variant Subtype Small Cell Lung Cancer
Poirier, J. T., Dobromilskaya, I., Moriarty, W. F., Peacock, C. D., Hann, C. L., & Rudin, C. M. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt130 · Cited by 133
Self-citationAchaete–scute homolog-1 and Notch in lung neuroendocrine development and cancer
Ball, D. (2004) · Cancer Letters · doi:10.1016/s0304-3835(03)00452-x · Cited by 126
ASH1 Gene Is a Specific Therapeutic Target for Lung Cancers with Neuroendocrine Features
Osada, H., Tatematsu, Y., Yatabe, Y., Horio, Y., & Takahashi, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1404 · Cited by 123
Conditional Survival Among Patients With Carcinoma of the Lung
Merrill, R. M., Henson, D. E., & Barnes, M. (1999) · CHEST Journal · doi:10.1378/chest.116.3.697 · Cited by 118
Transcriptional gene expression profiling of small cell lung cancer cells.
Pedersen, N. M., Mortensen, S., Sørensen, S. B., Pedersen, M. W., Rieneck, K., Bovin, L. F., & Poulsen, H. S. (2003) · PubMed · Cited by 117
Novel strategies for the treatment of small-cell lung carcinoma
William, W. N., & Glisson, B. S. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.90 · Cited by 97
Clingen, P. H., Silva, I. U. D., McHugh, P. J., Ghadessy, F. J., Tilby, M. J., Thurston, D. E., & Hartley, J. A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki639 · Cited by 71
O-Fucosylation of DLL3 Is Required for Its Function during Somitogenesis
Serth, K., Schuster-Gossler, K., Kremmer, E., Hansen, B., Marohn-Köhn, B., & Gossler, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123776 · Cited by 59
Loomes, K. M., Stevens, S. A., O’Brien, M. L., Gonzalez, D. M., Ryan, M. J., Segalov, M., Dormans, N. J., Mimoto, M. S., Gibson, J. D., Sewell, W., et al. (2007) · Developmental Dynamics · doi:10.1002/dvdy.21296 · Cited by 52
Puzanov, I. J., Lee, W., Chen, A. P., Calcutt, M. W., Hachey, D. L., VerMeulen, W. L., Spanswick, V. J., Liao, C., Hartley, J. A., Berlin, J. D., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2056 · Cited by 52
Anderson, W. C., Boyd, M. B., Aguilar, J., Pickell, B., Laysang, A., Pysz, M. A., Bheddah, S., Ramoth, J., Slingerland, B. C., Dylla, S. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125255 · Cited by 46
Self-citationStomatin-like Protein-1 Interacts with Stomatin and Is Targeted to Late Endosomes
Mairhofer, M., Steiner, M., Salzer, U., & Prohaska, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014993 · Cited by 41
Li, Y., & Linnoila, R. I. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0027oc · Cited by 31
Cited by
Batlle, E., & Clevers, H. (2017) · Nature Medicine · doi:10.1038/nm.4409 · Cited by 2,769
Strategies and challenges for the next generation of antibody–drug conjugates
Beck, A., Goetsch, L., Dumontet, C., & Corvaïa, N. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.268 · Cited by 2,271
Role of tumor microenvironment in tumorigenesis
Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., Gong, Z., Zhang, S., Zhou, J., Cao, K., et al. (2017) · Journal of Cancer · doi:10.7150/jca.17648 · Cited by 1,404
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Rudin, C. M., Poirier, J. T., Byers, L. A., Dive, C., Dowlati, A., George, J., Heymach, J. V., Johnson, J. E., Lehman, J. M., MacPherson, D., et al. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0133-9 · Cited by 1,254
Self-citationNotch signaling pathway: architecture, disease, and therapeutics
Zhou, B., Lin, W., Long, Y., Yang, Y., Zhang, H., Wu, K., & Chu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00934-y · Cited by 1,114
Metadata
- Authors
- Saunders, L. R., Bankovich, A. J., Anderson, W. C., Aujay, M. A., Bheddah, S., Black, K., Desai, R., Escarpe, P. A., Hampl, J., Laysang, A., Liu, D., Lopez-Molina, J., Milton, M., Park, A., Pysz, M. A., Shao, H., Slingerland, B., Torgov, M., Williams, S. A., Foord, O., Howard, P., Jassem, J., Badzio, A., Czapiewski, P., Harpole, D. H., Dowlati, A., Massion, P. P., Travis, W. D., Pietanza, M. C., Poirier, J. T., Rudin, C. M., Stull, R. A., & Dylla, S. J.
- Venue
- Science Translational Medicine
- Published
- 2015-08-26
- Volume
- 7
- Issue
- 302
- Pages
- 302ra136-302ra136
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W1822869875
- Cited by
- 600
- References
- 49
- FWCI
- 20.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.